Functional analysis of disease-causing mutations in human galactokinase
about
Sugar recognition by human galactokinaseIdentification and characterisation of human aldose 1-epimeraseGalactose toxicity in animalsMolecular structure of galactokinaseThe molecular architecture of human N-acetylgalactosamine kinaseHigh-throughput screening for human galactokinase inhibitors.Kinetic and functional analysis of L-threonine kinase, the PduX enzyme of Salmonella entericaInnovative therapy for Classic Galactosemia - tale of two HTS.Hepatic galactose metabolism quantified in humans using 2-18F-fluoro-2-deoxy-D-galactose PET/CTIdentification of Genes Conferring Tolerance to Lignocellulose-Derived Inhibitors by Functional Selections in Soil Metagenomes.Understanding the relationship between the primary structure of proteins and its propensity to be soluble on overexpression in Escherichia coli.GALK inhibitors for classic galactosemia.Comparative biochemical analysis of three members of the Schistosoma mansoni TAL family: Differences in ion and drug binding properties.Mechanistic studies on human N-acetylgalactosamine kinase.The evolution of a Web resource: The Galactosemia Proteins Database 2.0.Defective GALK1 does not phosphorylate GalGalactokinase deficiency induced cataracts in Indian infants: identification of 4 novel mutations in GALK gene.Laboratory diagnosis of galactosemia: a technical standard and guideline of the American College of Medical Genetics and Genomics (ACMG).Increased promiscuity of human galactokinase following alteration of a single amino acid residue distant from the active site.
P2860
Q21284392-FE7FC3AE-EA4D-4BEF-8107-2255F209FB48Q24302008-89B5F9B9-130F-4429-9B7C-886CD3B845C7Q24646350-BCBC5D5E-6B6F-427F-865A-2355EFA809AFQ27641419-540A7DEC-145E-4DC6-AD24-022E66655DBCQ28260722-91621569-228A-4BA0-B6DC-8ABA0B91CE5EQ33336038-B1E6267B-8F1A-4BC3-B0E5-AD93FFFE069EQ34017964-D68B346F-4830-4797-8E4A-9554D519F5A5Q34054239-4EE3A0C4-6710-41C7-B846-2B5B9FF562B9Q36125251-2895DCD2-CF5B-4EDF-AE8F-F7AA3000B107Q36457751-9317492A-1EB0-4129-A11C-4C5AD99F7356Q36518002-5CF7049E-659D-42E3-9E24-0971F8E9B19AQ38234643-5969ACB4-1327-44D3-A3B9-7248E1E6FBD8Q41758770-18630026-46EB-4E4A-BA0A-1E754868053FQ43252785-405D472A-93F3-4558-BA13-F8E6A0ABDA6CQ47725961-B2E1D8FB-CA87-4AE3-8584-C1A6ABB4069AQ50289240-ED0E3E87-BC16-4D7D-B44A-50E502841F26Q51337157-F40D002F-5CB5-43D5-9E39-25A4FE7C2236Q52742911-135B8EAA-639F-4CA7-B62C-8B7F8E611607Q54357270-BEC0D11A-A0C9-403D-89FF-151C68F601A4
P2860
Functional analysis of disease-causing mutations in human galactokinase
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Functional analysis of disease-causing mutations in human galactokinase
@ast
Functional analysis of disease-causing mutations in human galactokinase
@en
Functional analysis of disease-causing mutations in human galactokinase
@en-gb
Functional analysis of disease-causing mutations in human galactokinase
@nl
type
label
Functional analysis of disease-causing mutations in human galactokinase
@ast
Functional analysis of disease-causing mutations in human galactokinase
@en
Functional analysis of disease-causing mutations in human galactokinase
@en-gb
Functional analysis of disease-causing mutations in human galactokinase
@nl
prefLabel
Functional analysis of disease-causing mutations in human galactokinase
@ast
Functional analysis of disease-causing mutations in human galactokinase
@en
Functional analysis of disease-causing mutations in human galactokinase
@en-gb
Functional analysis of disease-causing mutations in human galactokinase
@nl
P2860
P1433
P1476
Functional analysis of disease-causing mutations in human galactokinase
@en
P2093
David J Timson
Richard J Reece
P2860
P304
P356
10.1046/J.1432-1033.2003.03538.X
P407
P577
2003-04-01T00:00:00Z